Aegera Therapeutics, part of Pharmascience Inc., is focused on developing targeted therapeutics to address major unmet medical needs. Aegera focuses on preclinical and early-stage clinical development through integration of "in-house" medicinal chemistry, biochemistry, cell biology, pharmacokinetics and in vivo pharmacology/efficacy. Aegera has one oncology program in clinical ...

 
July 26, 2011
Pharmascience Announces Strategic Investment in Preclinical-Stage Tyrosine Kinase Inhibitor Program
May 26, 2011
Pharmascience acquires Aegera Therapeutics Inc.